Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.120
+0.020 (0.95%)
Nov 20, 2024, 4:00 PM EST - Market closed
Minerva Neurosciences Employees
Minerva Neurosciences had 9 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$367,950
Market Cap
14.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Lifeward | 108 |
Flora Growth | 108 |
Cumberland Pharmaceuticals | 91 |
Sol-Gel Technologies | 36 |
IN8bio | 31 |
Microbot Medical | 22 |
Traws Pharma | 18 |
Can-Fite BioPharma | 8 |
NERV News
- 16 days ago - Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 7 months ago - Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 9 months ago - US FDA declines to approve Minerva Neurosciences' schizophrenia drug - Reuters
- 9 months ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences: There's Probably Time For One More Rally - Seeking Alpha
- 1 year ago - Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market - GlobeNewsWire